Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis (Q35940436)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis |
scientific article |
Statements
1 reference
Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis (English)
1 reference
Byron Hoogwerf
1 reference
Julia A Gaebler
1 reference
Gerardo Soto-Campos
1 reference
Peter Alperin
1 reference
Marc Cohen
1 reference
Amy Blickensderfer
1 reference
Matthew Wintle
1 reference
David Maggs
1 reference
Jenny Han
1 reference
Richard Pencek
1 reference
Barbara Peskin
1 reference
23 April 2012
1 reference
1 reference
255-264
1 reference
Identifiers
1 reference
1 reference
1 reference